Sauder Schelkopf is investigating litigation on behalf of nursing home residents who contracted COVID-19. As of April 22, 2020, the Wall Street Journal reported the “number of U.S. coronavirus-linked deaths in long-term care facilities including nursing homes has eclipsed 10,000. . . .” Nursing home residents are particularly vulnerable to the coronavirus and it has been widely reported that facilities throughout the country have seen numerous residents testing positive.
The Centers for Medicare & Medicaid Services issued guidance to nursing homes on March 9, 2020:
CMS Issues Clear, Actionable Guidance to Providers about COVID-19 Virus
Today, the Centers for Medicare & Medicaid Services (CMS) is taking action to protect the health and safety of our nation’s patients and providers in the wake of the 2019 Novel Coronavirus (COVID-19) outbreak. According to the latest data from the Centers for Disease Control and Prevention (CDC), seniors are at the greatest risk of serious illness due to COVID-19, which is why CMS is providing valuable information to providers who interact with patients in the hospice setting. To protect these vulnerable patients, CMS is amplifying its current health and safety requirements by delivering detailed guidance on the screening, treatment and transfer procedures healthcare workers must follow when interacting with patients to prevent the spread of COVID-19. CMS is also issuing additional guidance specific to nursing homes to help control and prevent the spread of the virus.
Sauder Schelkopf is a nationally recognized class action and personal injury law firm. The firm’s partners currently serve as court appointed lead counsel in courts across the country and have been selected by the National Trial Lawyers Association as some of the Top 100 Trial Lawyers in Pennsylvania since 2012. The attorneys at Sauder Schelkopf have recovered over $500 million on behalf of their clients and class members.
We Want to Hear from You
Please contact the lawyers at Sauder Schelkopf by filling out the form on this page or calling 888.711.9975